Crystagen 20 mg – 10 vials

Crystagen (also known as AC-6 or Glu-Asp-Pro) is a synthetic ultrashort tripeptide research compound (sequence: glutamic acid–aspartic acid–proline) developed as a Khavinson-style bioregulator targeting the immune system. It functions as an immunomodulatory agent that interacts at the epigenetic level with promoter regions of genes in immune cells, promoting complementary DNA-peptide interactions to enhance protein synthesis, normalize immune homeostasis, and support thymic function. In preclinical and clinical models (including studies on aging, stress, and immunodeficiency), Crystagen normalizes immunograms (e.g., restoring T-cell activity, lymphocyte proliferation, and cytokine balance), preserves thymic architecture (e.g., maintaining cortex-medulla differentiation in accelerated aging models), exhibits immunogeroprotective effects against radiation or age-related decline, reduces infection susceptibility (e.g., lower respiratory viral infections in high-stress groups like athletes), and shows potential antitumor and anti-inflammatory properties. Compared to natural thymus extracts, its short structure confers high stability, bioavailability, and targeted epigenetic regulation without significant side effects. Crystagen is utilized in research to investigate mechanisms of immune restoration, thymic peptide signaling, age-related immunosenescence, stress-induced immunosuppression, preventive strategies for infectious diseases, cancer immunotherapy adjuncts, and the broader roles of short peptides in epigenetic control of cellular immunity, tissue homeostasis, and longevity